05334DAA5
Auxilium Pharmaceuticals Inc
Could not find a ticker for this position, may be a filing error
A specialty biopharmaceutical company that developed and marketed drugs for men's health, urology, and orthopedics. Its best-known products were the testosterone treatments Testim (a gel) and Testopel (implantable pellets), plus Xiaflex, an injected enzyme used to treat Dupuytren's contracture of the hand and Peyronie's disease. Founded in Pennsylvania in 1999, its name comes from the Latin word for "help" or "remedy." In 2015 it was acquired by Endo International, which took over its portfolio.
NOTEUnderlying: AUXLCUSIP: 05334DAA5HealthcareUS1 derivative reporter
1.50% Convertible Senior Notes due 2018
No tracked superinvestor held this security as stock in this period — only the derivative positions below reference it.
Derivative Reporters
Investor
Kind
13F reported value
Quantity
Change
